THE BASIC PRINCIPLES OF AGO TUMOR

Hormonal therapy continues to be the therapy of first choice for metastatic patients with endocrine-responsive breast most cancers (LoE 1a A, AGO ++). The sequential use with the out there medication depends on the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at the time of diagnosis of relapse is usually recommended Ea